Showing results (2481-2490 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|February 21, 2023
CT Radiomics for Predicting Pathological Complete Response of Axillary Lymph Nodes in Breast Cancer After Neoadjuvant Chemotherapy: A Prospective StudyYan-Ling Li, Li-Ze Wang, Qing-Lei Shi, et al.
The Oncologist|January 31, 2023
The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti-Cancer TreatmentKarin Purshouse, John P Thomson, Mahéva Vallet, et al.
The Oncologist|February 27, 2023
Patient Engagement With Early Stage Advance Care Planning at a Comprehensive Cancer CenterDonna S Zhukovsky, Pamela Soliman, Diane Liu, et al.
The Oncologist|March 9, 2023
Practical Guidance for the Management of Adverse Events in Patients with KRASG12C-Mutated Non-Small Cell Lung Cancer Receiving AdagrasibJun Zhang, Melissa Johnson, Minal Barve, et al.
The Oncologist|March 21, 2023
The Impact of HIV Infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Patients with Breast CancerDaniel S O'Neil, Oluwatosin A Ayeni, Hayley A Farrow, et al.
The Oncologist|March 13, 2023
Almonertinib Combined with Anlotinib and Temozolomide in a Patient with Recurrent Glioblastoma with EGFR L858R MutationZhiwei Hou, Huaguo Wu, Ningning Luo, et al.
The Oncologist|March 14, 2023
Patients' Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19Cristiane Decat Bergerot, Jasnoor Malhotra, Paulo Bergerot, et al.
The Oncologist|February 23, 2023
Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort StudyBruce C Tiu, Ian A Strohbehn, Sophia Zhao, et al.
The Oncologist|November 26, 2025
Immune-related adverse events, survival outcomes, and next steps in patients with stage III melanoma: real-world experience at a National Cancer Institute-designated Comprehensive Cancer CenterKevin G Zablonski, Jarred M Boone, Seunghee Margevicius, et al.
The Oncologist|November 19, 2025
Impact of carboplatin schedule on pCR in a modified KEYNOTE-522 regimen with dose-dense AC for triple negative breast cancerKennedi G Satterfield, Michael Berger, Allison Reed, et al.
Pageof 571